Search Results (1 to 10 of 2610 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 709 Journal of Medical Internet Research
- 495 JMIR Research Protocols
- 304 JMIR Formative Research
- 241 JMIR mHealth and uHealth
- 110 JMIR Mental Health
- 101 JMIR Public Health and Surveillance
- 82 Online Journal of Public Health Informatics
- 67 JMIR Medical Informatics
- 66 JMIR Human Factors
- 60 JMIR Cancer
- 49 JMIR Pediatrics and Parenting
- 41 JMIR Aging
- 37 JMIR Medical Education
- 37 JMIR Serious Games
- 29 JMIR Diabetes
- 24 Interactive Journal of Medical Research
- 24 JMIR Perioperative Medicine
- 22 JMIR Dermatology
- 17 Iproceedings
- 16 JMIR Cardio
- 16 JMIR Rehabilitation and Assistive Technologies
- 14 JMIR Infodemiology
- 11 JMIR Nursing
- 9 JMIRx Med
- 8 Journal of Participatory Medicine
- 7 JMIR AI
- 6 JMIR Bioinformatics and Biotechnology
- 3 JMIR Biomedical Engineering
- 2 Asian/Pacific Island Nursing Journal
- 2 Medicine 2.0
- 1 JMIR Neurotechnology
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR XR and Spatial Computing (JMXR)

deal: samen werken aan duurzame zorg [Article in Dutch](https://www.rvo.nl/sites/default/files/2024-12/C-
J Med Internet Res 2025;27:e67538
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

Several recent Canadian population-based studies have shown that many patients at high CVD risk continue to have low-density lipoprotein cholesterol (LDL-C) levels well above the guideline targets [2,3]. LDL-C has been extensively studied and described as a causal factor for CVD [4]. LDL-C levels above the target can result from multiple factors such as insufficient LDL-C lowering with statins, statin-related side effects, suboptimal medication adherence, and treatment inertia [5].
JMIR Cardio 2025;9:e58124
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section